Bone Marrow Transplantation

Top Story

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience
September 18, 2019
In the Journals

Human herpesvirus 6B linked to increased mortality among certain HSCT recipients

September 12, 2019
Detection of human herpesvirus 6B in bronchoalveolar lavage fluid appeared associated with higher risk for mortality among allogeneic hematopoietic stem cell transplant…
Advanced Practice

APPs can serve as ‘advocate, coordinator’ for patients with chronic GVHD

HemOnc Today, September 10, 2019
Linda M. Perry, MS, PA-C
Chronic graft-versus-host disease can be a debilitating and even life-threatening complication of allogeneic hematopoietic stem cell transplantation. Approximately 30%…

Light therapy could prevent cancer treatment-related oral mucositis

September 6, 2019
Light therapy appeared to be an effective intervention for the prevention of painful oral mucositis associated with cancer treatment, according to results of a…
More Headlines »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
Meeting News

VIDEO: Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients

October 14, 2017
More »

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »